To the full analysis
Buyback calculator for AbCellera Biologics
AbCellera Biologics stock: key metrics
ABCLAbCellera Biologics had an operating margin of −289% and a return on invested capital (ROIC) of −32% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2018 | 100.0% | −8.5% | 3.5% |
| 2019 | 100.0% | −35.5% | −19.0% |
| 2020 | 88.4% | 66.9% | 51.0% |
| 2021 | 87.9% | 54.5% | 40.9% |
| 2022 | 86.3% | 44.6% | 32.7% |
| 2023 | 100.0% | −623.8% | −385.0% |
| 2024 | 100.0% | −1,091.7% | −564.8% |
| 2025 | 61.6% | −289.0% | −194.9% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2018 | 2.7% | −16.3% | 1.4% |
| 2019 | −21.6% | −45.8% | −9.4% |
| 2020 | 14.3% | 93.0% | 11.8% |
| 2021 | 15.0% | 48.9% | 11.6% |
| 2022 | 12.9% | 37.2% | 10.3% |
| 2023 | −12.7% | −41.7% | −9.8% |
| 2024 | −15.4% | −51.5% | −12.0% |
| 2025 | −15.1% | −32.0% | −10.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Oct 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.